Literature DB >> 10491823

Effect of compression on the cochlear nerve: a short- and long-term electrophysiological and histological study.

T Hatayama1, T Sekiya, S Suzuki, T Iwabuchi.   

Abstract

The short- and long-term effects of static compression of the cochlear nerve were studied in dogs. The nerve was exposed in the cerebellopontine angle and a modified aneurysm clip was applied to reduce the diameter of the nerve trunk to 50%, 40%, 30% or 20% of normal (designated respectively as 50%, 60%, 70%, and 80% compression). Brainstem auditory evoked potentials (BAEPs) were monitored intraoperatively and post-operatively. The animals were sacrificed between 5 and 119 days after nerve compression and temporal bones were examined histologically. In the 50% compression group, all peaks except peak I disappeared immediately after nerve compression. After release of the clip, however, peak II and subsequent components recovered and prolonged interpeak latency (IPL) between peaks I and IV normalized within 7 days. In the 60% compression group, recovery was incomplete for as long as 49 days after compression. Significant histological changes were not always reflected in the electrophysiological recordings, as shown by the finding of multiple cavitations at the compressed portion of the cochlear nerve in cases in which conduction block of cochlear nerve impulses was reversible. In the 70% compression group, peak IV did not reappear for more than 1 week, and histological examination revealed severe damage to all cochlear nerve fibers except those from the apical turn, which lie in the center of the cochlear nerve trunk. Severe injury occurred to the cochlear nerve fibers that are situated more superficially in the nerve, which are tonotopically responsible for the perception of high-frequency sound and the generation of BAEPs. This means that the BAEP changes due to cochlear nerve compression would be detectable by BAEP monitoring, although changes in the apical region of the cochlea are not fully detectable by BAEP monitoring. In the 80% compression group, all peaks except peak I were lost permanently and the amplitude of peak I, which had been preserved in the acute phase, gradually decreased. Reversibility of impaired cochlear nerve impulse conduction was related to the severity of compression, and at some level of compression between 70% and 80% the nerve fibers generating BAEPs permanently lost the ability to conduct electrical impulses proximal to the site of compression. In the 70% and 80% compression groups, the amplitude of peak I gradually decreased over the first 30 days after compression and did not change significantly thereafter. Histologically, the branches of the internal auditory artery were resilient to compression, although they are easily avulsed due to stretch force. Furthermore, retrograde degeneration of cochlear neurons triggered by compression at the cisternal portion of the cochlear nerve was apparent. Such slowly progressive degeneration of nerve fibers may play a part in development of the delayed postoperative hearing disturbance.

Entities:  

Mesh:

Year:  1999        PMID: 10491823     DOI: 10.1080/01616412.1999.11740983

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

Review 1.  [Neuroprotective medication in vestibular schwannoma surgery].

Authors:  C Scheller; E Herzfeld; C Strauss
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

2.  Patterns of hearing loss following retrosigmoid excision of unilateral vestibular schwannoma.

Authors:  Melissa J Babbage; Melanie B Feldman; Greg A O'Beirne; Martin R Macfarlane; Philip A Bird
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-01

Review 3.  Hearing loss in hydrocephalus: a review, with focus on mechanisms.

Authors:  David Satzer; Daniel J Guillaume
Journal:  Neurosurg Rev       Date:  2015-08-18       Impact factor: 3.042

4.  ASNM position statement: intraoperative monitoring of auditory evoked potentials.

Authors:  William Hal Martin; Mark M Stecker
Journal:  J Clin Monit Comput       Date:  2008-02       Impact factor: 1.977

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.